logo
Plus   Neg
Share
Email

Dr. Reddy's Labs Launches Lansoprazole DR Orally Disintegrating Tablets In U.S.

Dr. Reddy's Laboratories Ltd. (RDY) said Monday that it has launched Lansoprazole DR Orally Disintegrating Tablets, a therapeutic equivalent generic version of Prevacid SoluTab Delayed-Release Orally Disintegrating Tablets, 15 mg and 30 mg, approved by the U.S. Food and Drug Administration.

The Prevacid brand and generic had U.S. sales of about $87 million MAT for the most recent twelve months ending in December 2020 according to IMS Health.

Dr. Reddy's said that its Lansoprazole DR Orally Disintegrating Tablets are available in
15 mg and 30 mg tablets in unit-dose packages of 100.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Alaska Airlines is set to use sustainable aviation fuel (SAF) made from municipal solid waste following a partnership with SkyNRG Americas, claimed to be the pioneer and global leader for SAF. Alaska Airlines is one of the most fuel-efficient airlines in the U.S. with a strong commitment to sustainability. Discount retailer Dollar General said it is planning to hire up to 20,000 new employees this spring. The company will host in-person and virtual hiring events from April 19 through April 23 to support ongoing efforts across store, distribution, transportation and corporate operations. The retailer provided a comprehensive list of hiring events and available positions on its Careers website. Wells Fargo & Co. (WFC) on Tuesday reported net income applicable to common stock of $4.74 billion or $1.05 per share for the first quarter, sharply higher than $653 million or $0.01 per share in the year-ago quarter. Revenue for the quarter increased 2 percent to $18.06 billion from $17.72 billion...
Follow RTT